Table 4. Clinical characteristics of patients with DIIP (1).
No. | Age | Sex | BMI | Disease duration (year) |
Smoking | type of Ps | Baseline KL-6 levels (U/ml) |
underlying IP | prior biologic | Causative biologic of DIIP |
---|---|---|---|---|---|---|---|---|---|---|
1 | 64 | F | 27.4 | 1 | - | PsV | 2149 | + | - | UST |
2 | 75 | M | 19.5 | 30 | + | PsV | 467 | + | - | UST |
3 | 65 | M | 25.1 | 6 | + | PsV | 829 | - | IFX | UST |
4 | 79 | M | 21.3 | 22 | + | PsV | 332 | + | SEC | GUS |
5 | 77 | M | 21.3 | 20 | + | PsV | 561 | + | UST | SEC |
6 | 56 | F | 25.2 | 39 | - | PsA | 1715 | - | ADA | SEC |